Heparan sulfate proteoglycan in Alzheimer’s disease: aberrant expression and functions in molecular pathways related to amyloid-β metabolism
- DOI
- 10.1152/ajpcell.00247.2022
- Published
- 2023-04-01
- Container
- American Journal of Physiology-Cell Physiology
- Publisher
- American Physiological Society
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1152/ajpcell.00247.2022,
title = {Heparan sulfate proteoglycan in Alzheimer’s disease: aberrant expression and functions in molecular pathways related to amyloid-β metabolism},
author = {Ilayda Ozsan McMillan and Jin-Ping Li and Lianchun Wang},
year = {2023},
journal = {American Journal of Physiology-Cell Physiology},
doi = {10.1152/ajpcell.00247.2022},
url = {https://doi.org/10.1152/ajpcell.00247.2022}
}RIS
TY - JOUR TI - Heparan sulfate proteoglycan in Alzheimer’s disease: aberrant expression and functions in molecular pathways related to amyloid-β metabolism AU - Ilayda Ozsan McMillan AU - Jin-Ping Li AU - Lianchun Wang PY - 2023 JO - American Journal of Physiology-Cell Physiology DO - 10.1152/ajpcell.00247.2022 UR - https://doi.org/10.1152/ajpcell.00247.2022 ER -
APA
McMillan, I. O., Li, J., & Wang, L. (2023). Heparan sulfate proteoglycan in Alzheimer’s disease: aberrant expression and functions in molecular pathways related to amyloid-β metabolism. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00247.2022
Source records
- crossref · retrieved 2026-09-25T22:31:22.885Z